Clinical trial
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring Containing Dapivirine for the Prevention of HIV-1 Infection in Women
NCT01617096 is registered in ClinicalTrials.gov with International Partnership for Microbicides, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring Containing Dapivirine for the Prevention of HIV-1 Infection in Women
- Lead sponsor
- International Partnership for Microbicides, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 24, 2012
- Completion date
- December 31, 2015
- Enrollment
- 2,629 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.